Jemincare

This study is for people with advanced lung cancer that has a specific genetic change called KRAS G12C and has worsened after initial treatments. It will compare a new, targeted oral drug (JMKX001899) designed to block this mutation against the standard intravenous chemotherapy (…

This study is testing an investigational injection called JYB1904 for adults with chronic spontaneous urticaria, a condition causing long-lasting, itchy hives that are not well-controlled by standard allergy medications. The main goal is to see if the injection is better than a p…

This study is testing an investigational injection called JYB1904 to see if it can help control symptoms in adults with year-round allergic rhinitis. Participants will receive either the JYB1904 injection or a placebo (inactive) shot, in addition to their standard allergy medicat…

This is an early safety study to see if a single dose of an experimental drug called JMKX003142 affects the heart's electrical rhythm in healthy people. The drug is being developed for a genetic kidney disease called ADPKD. Researchers will compare the drug's effects to a placebo…

This early study aims to understand how the body absorbs, processes, and eliminates an experimental drug called JMKX003142. It will involve 8 healthy male volunteers. Researchers will track how much of the drug gets into the bloodstream and how it leaves the body to help design f…

This early-stage study aims to understand how a new experimental drug for a genetic kidney disease (ADPKD) interacts with two common medications: amiodarone (for heart rhythm) and febuxostat (for gout). Researchers will give all three drugs to 48 healthy Chinese volunteers to mea…